JPS6257566A - Coating agent for treating dermatophytosis - Google Patents

Coating agent for treating dermatophytosis

Info

Publication number
JPS6257566A
JPS6257566A JP19495485A JP19495485A JPS6257566A JP S6257566 A JPS6257566 A JP S6257566A JP 19495485 A JP19495485 A JP 19495485A JP 19495485 A JP19495485 A JP 19495485A JP S6257566 A JPS6257566 A JP S6257566A
Authority
JP
Japan
Prior art keywords
foot
athlete
coating agent
stratum corneum
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP19495485A
Other languages
Japanese (ja)
Inventor
岡田 実郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishii Iron Works Co Ltd
Original Assignee
Ishii Iron Works Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishii Iron Works Co Ltd filed Critical Ishii Iron Works Co Ltd
Priority to JP19495485A priority Critical patent/JPS6257566A/en
Publication of JPS6257566A publication Critical patent/JPS6257566A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 (産業上の利用分野) この発明は、水虫の治療に使用する塗布剤に関するもの
である。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) This invention relates to a liniment for use in treating athlete's foot.

(従来の技術) 水虫の治療に対しては、これまで数多くの薬物をはじめ
治療器具が開発きれ、市販されているが残念ながらいま
だに確定的なものはない。
(Prior Art) For the treatment of athlete's foot, a large number of drugs and therapeutic devices have been developed and are commercially available, but unfortunately there is still no definitive treatment.

ちなみに薬物治療剤として一般に普及しているものは、
鋼又は銀などを主要有効成分とした軟膏類がある。
By the way, the drugs that are commonly used as drug treatments are:
There are ointments whose main active ingredients are steel or silver.

また、薬物利用の治療効果を補助するものとして、治療
用器具がある。水虫すなわち白罫菌、近紅色菌が汗など
による湿り気の多い足指の間に発生しやすい点を考え、
このような患部を常に乾燥した状態に保つための足指リ
ングなどがそれである。
In addition, there are therapeutic devices that assist the therapeutic effects of drug use. Considering the fact that athlete's foot, i.e., white streak fungus and near red fungus, are likely to occur between toes where there is a lot of moisture due to sweat,
Examples include toe rings that keep the affected area dry at all times.

ざらに赤外線照射による方法や、最近においては、レー
ザーを患部へ照射する物理療法としての治療方法なども
ある。
There are methods that use infrared irradiation, and more recently, physical therapy methods that involve irradiating the affected area with a laser.

しかし、いずれも前述したとおり、これで確実に完全治
癒できるというものはない。本発明は薬物治療剤として
の塗布剤を提供することを目的とするものである。
However, as mentioned above, there is no guarantee that this will completely cure the condition. An object of the present invention is to provide a liniment as a drug therapeutic agent.

(発明が解決しようとする問題点) ところで最も薬物治療剤として普及している前記軟膏類
は、周知のとおりいずれも患部に塗布するものである。
(Problems to be Solved by the Invention) As is well known, the ointments that are most popular as drug therapeutic agents are those that are applied to the affected area.

しかし、患部はそのほと八とが足指の間が多り、シたが
って、充分に指と指との間にすり込ませないと、その薬
効を満足させることはできない欠点がある。
However, most of the affected areas are between the toes, and therefore the medicinal effect cannot be achieved unless it is thoroughly rubbed between the toes.

とくに軟膏類の薬物を用いた場合、完全治癒にいたらず
治ったと思ったらまた再発するといった悪循環を繰返す
傾向が高い。これは治療者の治療態度にも問題があるが
、軟膏であるということから(る薬物そのものがもつ浸
透性に問題があるからである。
Particularly when drugs such as ointments are used, there is a high tendency for the disease to repeat itself in a vicious cycle where the disease does not completely heal, and then it occurs again. This is due to the therapist's treatment attitude, but also because it is an ointment (there is a problem with the permeability of the drug itself).

指摘するまでもなく水虫は、主として皮膚の角質層に寄
生するものであるため、その角質層の深部まで薬物が浸
透しなければ完治するには至らないものである。軟膏で
はこの浸透性が低い。
Needless to point out, athlete's foot is a parasite that mainly infects the stratum corneum of the skin, and therefore cannot be completely cured unless the drug penetrates deep into the stratum corneum. Ointments have low penetration.

そこで視点を変えて考案きれたのが、治療器具としての
足指のリングがある。これは水虫というカビの繁殖を増
長きせる湿り気を患部より取り除く意味で有効である。
What I was able to come up with after changing my perspective was a toe ring that could be used as a therapeutic device. This is effective in removing moisture from the affected area, which can increase the growth of a fungus called athlete's foot.

しかし、これとて適切な薬物との併用がなければ意味を
なざない。
However, this is of no use unless it is used in combination with the appropriate drug.

ざらに赤外線照射による物理的治療法や、ざらに新しい
レーザー照射による治療法は、従来の薬物による有効性
よりはかなりの期待がもてるものであるが、一般家庭に
おける治療法としては、レーザー発振装置など大がかり
の装置が必要となり、誰でもが容易に利用できるもので
はない。通院による治療にたよらざるを得ないという欠
点がある。
Physical therapy using infrared irradiation and Zara's newer therapy using laser irradiation are much more promising than conventional drugs, but laser irradiation is a treatment method that can be used at home. This method requires large-scale equipment, such as equipment, and is not something that everyone can easily use. The drawback is that it requires outpatient treatment.

いずれにしても従来の薬物をはじめその他の治療法では
、一時的な、かつ表面的な治癒は可能でも、完全治mま
で結び付けることば伊わめて困難であるという欠点があ
る。
In any case, conventional drugs and other treatment methods have the disadvantage that, although temporary and superficial cures are possible, it is extremely difficult to achieve complete cure.

(問題点を解決するための手段) そこで本発明では、従来の薬物のもつ欠点を解消するた
め、もっとも水虫の繁殖床となる角質層への浸透性の高
い、しかも角質溶解性をもつサルチル酸を吸湿性および
消毒性、殺菌性をもったエチルアルコールに重量比で6
%の割合で溶解させたものを患部へ塗布して、水虫とい
われる白w#菌ないし逼紅色国を死滅させることを狙っ
たものである。
(Means for Solving the Problems) Therefore, in order to eliminate the drawbacks of conventional drugs, the present invention uses salicylic acid, which has the highest permeability to the stratum corneum, which is the breeding ground for athlete's foot, and has keratolytic properties. in a weight ratio of 6 to ethyl alcohol, which has hygroscopic, disinfectant, and bactericidal properties.
The aim is to kill the white fungus known as athlete's foot or the scarlet fungus by applying it to the affected area.

(実施例) サルチル酸10gを200ccのエチルアルコールに溶
解させた重量比ht駕)で6%の溶解液を作り、これを
清潔にした患部に、1日2回の割合で1週間継続して塗
布した。
(Example) A 6% solution was prepared by dissolving 10 g of salicylic acid in 200 cc of ethyl alcohol (weight ratio ht), and this was applied to the clean affected area twice a day for one week. Coated.

塗布を開始してから2〜3日目白病菌の温床である角質
層は塗布剤に含まれたサルチル酸の溶解性に基づき真皮
より剥離きれた。
Two to three days after the start of application, the stratum corneum, which is a breeding ground for leprosy fungi, was completely peeled off from the dermis due to the solubility of the salicylic acid contained in the coating agent.

ざらに塗布を継続し、約1週間で角質層を含む表皮部分
が徐々に剥離され、白癖菌は撲滅され、表皮部分は白く
なり治癒さ′れノこ。
Continue to apply it roughly, and in about a week the epidermis including the stratum corneum will gradually exfoliate, the white fungus will be eradicated, and the epidermis will turn white and heal.

ただ角質層の厚とは個人差がある。したがって、1週間
程度で治ぬするケースもあったが、完全治癒を狙って少
なくとも2週間以上の継続塗布が好ましいとの結論を得
た。
However, the thickness of the stratum corneum varies from person to person. Therefore, although some cases were cured within about one week, it was concluded that continuous application for at least two weeks or more is preferable for complete recovery.

(効果) 以上説明したことから理解されるように、本発明による
水虫治療用塗布剤の第1の特徴は、水虫の繁殖床となる
角質層の溶解性と、とくに角質層への浸透性を有するサ
ルチル酸を消毒性(殺菌性)および脱水性を有するエチ
ルアルコールに溶解きせたものであるため、従来の軟膏
剤等に比較し、検閲効果が高い。
(Effects) As can be understood from the above explanation, the first feature of the topical agent for treating athlete's foot according to the present invention is the solubility of the stratum corneum, which is the breeding ground for athlete's foot, and especially the ability to penetrate the stratum corneum. Since it is made by dissolving salicylic acid in ethyl alcohol, which has disinfectant (sterilizing) and dehydrating properties, it has a higher censoring effect than conventional ointments.

すなわち塗布剤の角質層への浸透性が顕著であるため、
完全治餞カ達成で伊る点にある。
In other words, the permeability of the liniment into the stratum corneum is remarkable;
The patient is on the verge of achieving complete recovery.

ざらに第2の特徴は、塗布剤としての性状が液体である
ため、患部への塗布が誰でも容易に手軽にできることで
ある。
The second feature is that since the liniment is liquid, anyone can easily apply it to the affected area.

すなわち従来の軟膏剤にくらべあるいは赤外線照射やレ
ーザー照射による方法に比較し、その用法が筒便で、し
かも患部である足指の間にも塗布が容易であるため、塗
布を面倒がるずぼらな思考にあっても、その治療効果が
高いことであその上、エチルアルコールのもつ殺菌性や
脱水性が水虫繁殖の環境を一掃するに役立ち、治療薬と
しての薬効をざらに高めるため、前記第1の特徴とあい
まって従来の薬物に比較し、完全治題力呵能である点に
ある。
In other words, compared to conventional ointments or methods using infrared irradiation or laser irradiation, it can be used in the feces and is easy to apply between the toes, which is the affected area, so it is not a sloppy person who does not have to worry about applying it. In addition to its high therapeutic effect, ethyl alcohol's bactericidal and dehydrating properties help wipe out the environment in which athlete's foot breeds, greatly increasing its medicinal efficacy as a therapeutic drug. Combined with the first feature, it is completely effective in treating the problem compared to conventional drugs.

Claims (1)

【特許請求の範囲】[Claims] サルチル酸をエチルアルコールに重量比で6%の割合で
溶解した水虫治療用塗布剤。
A liniment for treating athlete's foot that contains salicylic acid dissolved in ethyl alcohol at a ratio of 6% by weight.
JP19495485A 1985-09-05 1985-09-05 Coating agent for treating dermatophytosis Pending JPS6257566A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19495485A JPS6257566A (en) 1985-09-05 1985-09-05 Coating agent for treating dermatophytosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19495485A JPS6257566A (en) 1985-09-05 1985-09-05 Coating agent for treating dermatophytosis

Publications (1)

Publication Number Publication Date
JPS6257566A true JPS6257566A (en) 1987-03-13

Family

ID=16333089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19495485A Pending JPS6257566A (en) 1985-09-05 1985-09-05 Coating agent for treating dermatophytosis

Country Status (1)

Country Link
JP (1) JPS6257566A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290361A (en) * 1991-01-24 1994-03-01 Wako Pure Chemical Industries, Ltd. Surface treating cleaning method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE MERCK INDEX TENTH EDITION=1983 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290361A (en) * 1991-01-24 1994-03-01 Wako Pure Chemical Industries, Ltd. Surface treating cleaning method

Similar Documents

Publication Publication Date Title
Jaffary et al. A comparison between the effects of glucantime, topical trichloroacetic acid 50% plus glucantime, and fractional carbon dioxide laser plus glucantime on cutaneous leishmaniasis lesions
Mohs et al. Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma
Hirose et al. Topical treatment of resistant warts with glutaraldehyde
JP2019502750A (en) How to remove a tattoo
Nolting Non-traumatic removal of the nail and simultaneous treatment of onychomycosis
Statham et al. Short‐contact dithranol therapy—a comparison with the Ingram regime
US6503946B1 (en) Preparation for warts
Hancox et al. Treatment of molluscum contagiosum with the pulsed dye laser over a 28-month period
Langsdon et al. Chemical face peeling
JPS6257566A (en) Coating agent for treating dermatophytosis
RU2633060C2 (en) Peeling compositions containing trichloroacetic acid (tca) and phenol to reduce burning caused by peeling with tca
CA2809793C (en) Treatment of fungal infections
JPS6411619B2 (en)
RU2266743C2 (en) Method for treating onychomycosis cases with combined preparation
Edwards Theodoric of Cervia, a medieval antiseptic surgeon
RU2286791C1 (en) Method for cicatrice treatment
RU2181591C2 (en) Method of preparing substance for destruction of microcirculatory alveus of topical cutaneous formations
RU2145224C1 (en) Drug for vein recovery
CA2100314C (en) Pharmaceutical composition for the treatment of chronic skin ulcers
RU2600033C2 (en) Method of producing substance for destruction of microvasculature of removed skin formation
RU2195947C2 (en) Method for treating osteochondropathy cases
WO2017146602A1 (en) Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis
Warts medical
US4039686A (en) Mange cure
JPS6183121A (en) Remedy for ischemic ulcer